JPMorgan Chase is facing a lawsuit from its employees, who allege that the company's prescription drug plan, managed by CVS Health, has resulted in exorbitant medication prices. This class action lawsuit claims that the high costs have significantly increased expenses for workers. The legal action adds to the growing scrutiny of pharmacy benefit managers (PBMs) and their pricing practices, which have been criticized by various stakeholders, including Fortune 500 companies. In a related development, Wells Fargo has also initiated legal proceedings against JPMorgan over a fraudulent real estate deal. Additionally, the SEC has filed a lawsuit against three former executives of Allarity Therapeutics for allegedly concealing the lack of regulatory approval for the company's flagship drug application. A former executive from Evolution Healthcare has accused a benefits consultant of hiding prescription drug rebates, which reportedly made the company highly profitable.